dos Santos ES, Ramos JC, Normando AGC, Leme AFP. Prognostic value of the immunohistochemical expression of vascular endothelial growth factors in malignant salivary gland neoplasms: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26 (2):e126-35.
doi:10.4317/medoral.23974
https://dx.doi.org/doi:10.4317/medoral.23374
1. Zhang J, Peng B, Chen X. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res. 2005;11:7334-43. |
PMid:16243805 |
2. Maulik N, Das DK. Redox signaling in vascular angiogenesis. Free Radic Biol Med. 2002;33:1047-60. |
PMid:12374616 |
3. Kieser A, Weich H, Brandner G. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene. 1994; 9:963-9. |
PMid:8108142 |
4. Zang J, Li C, Zhao LN, Shi M, Zhou YC, Wang JH, et al. Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis. Head Neck. 2013;35:1507-14. |
PMid:22987573 |
5. Fonseca FP, Basso MP, Mariano FV, Kowalski LP, Lopes MA, Martins MD, et al. Vascular endothelial growth factor immunoexpression is increased in malignant salivary gland tumors. Ann Diagn Pathol. 2015;19:169-74. |
PMid:25900273 |
6. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. |
PMid:19621072 PMCid:PMC2707599 |
7. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. |
PMid:27919275 PMCid:PMC5139140 |
8. Hayden JA van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280-6. |
PMid:23420236 |
9. Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144:427-37. |
PMid:16549855 |
10. Leeflang MM, Deeks JJ, Takwoingi Y, Macaskill P. Cochrane diagnostic test accuracy reviews. Syst Rev. 2013;2:82. |
PMid:24099098 PMCid:PMC3851548 |
11. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401‐6. |
PMid:21208779 |
12. Hao L, Xiao-lin N, Qi C, Yi-ping Y, Jia-quan L, Yan-ning L. Nerve growth factor and vascular endothelial growth factor: retrospective analysis of 63 patients with salivary adenoid cystic carcinoma. Int J Oral Sci. 2010;2:35-44. |
PMid:20690417 PMCid:PMC3475596 |
13. Ou Yang KX1, Liang J, Huang ZQ. Association of clinicopathologic parameters with the expression of inducible nitric oxide synthase and vascular endothelial growth factor in mucoepidermoid carcinoma. Oral Dis. 2011;17:590-6. |
PMid:21624013 |
14. Shi L, Chen XM, Wang L, Zhang L, Chen Z. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome. Cancer. 2007;109:1523-31. |
PMid:17342767 |
15. Lee SK, Kwon MS, Lee YS, Choi SH, Kim SY, Cho KJ, et al. Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study. World J Surg Oncol. 2012;11:266. |
PMid:23231994 PMCid:PMC3556129 |
16. Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, et al. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med. 2003;32:552-61. |
PMid:12969230 |
17. Park S, Nam SJ, Keam B, Kim TM, Jeon YK, Lee SH, et al. VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma. Cancer Res Treat. 2016;48:518-26. |
PMid:26194375 PMCid:PMC4843710 |
18. Lequerica-Fernández P, Astudillo A, de Vicente JC. Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis. Anticancer Res. 2007;27:3661-6. |
PMid:17972532 |
19. Lequerica-Fernández P, Peña I, Villalaín L, Rosado P, de Vicente JC. Carcinoma of the parotid gland: developing prognostic indices. Int J Oral Maxillofac Surg. 2011;40:821-8. |
PMid:21612890 |
20. Haymerle G, Schneider S, Harris L, Häupl T, Schopper C, Pammer J, et al. Minor salivary gland carcinoma: a review of 35 cases. Eur Arch Otorhinolaryngol. 2016;273:2717-26. |
PMid:26498950 |
21. Stárek I, Salzman R, Kučerová L, Skálová A, Hauer L. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma. Pathol Res Pract. 2015;211:759-65. |
PMid:26296919 |
22. Doi R, Kuratate I, Okamoto E, Ryoke K, Ito H. Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas. J Oral Pathol Med. 1999;28:259-63. |
PMid:10426198 |
23. El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol. 2017;66:10-12. |
PMid:28583885 |
24. Ceci C, Atzori MG, Lacal PM, Graziani G. Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models. Int J Mol Sci. 2020;21:1388. |
PMid:32085654 PMCid:PMC7073125 |
25. Zong S, Li H, Shi Q, Liu S, Li W, Hou F. Prognostic significance of VEGF-C immunohistochemical expression in colorectal cancer: A meta-analysis. Clin Chim Acta. 2016;458:106-14. |
PMid:27155587 |
26. Jiang H, Shao W, Zhao W. VEGF-C in non-small cell lung cancer: meta-analysis. Clin Chim Acta. 2014;427:94-9. |